These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1628589)

  • 1. Phenytoin pharmacokinetics: before and after folic acid administration.
    Berg MJ; Fincham RW; Ebert BE; Schottelius DD
    Epilepsia; 1992; 33(4):712-20. PubMed ID: 1628589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease of serum folates in healthy male volunteers taking phenytoin.
    Berg MJ; Fincham RW; Ebert BE; Schottelius DD
    Epilepsia; 1988; 29(1):67-73. PubMed ID: 3338424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid improves phenytoin pharmacokinetics.
    Berg MJ; Stumbo PJ; Chenard CA; Fincham RW; Schneider PJ; Schottelius DD
    J Am Diet Assoc; 1995 Mar; 95(3):352-6. PubMed ID: 7860949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of Km for phenytoin dosage after folate addition to patient regimen.
    Berg MJ; Ebert BE; Rivey MP; Schottelius DD
    Ther Drug Monit; 1987 Sep; 9(3):304-5. PubMed ID: 3672574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenytoin-folic acid interaction.
    Lewis DP; Van Dyke DC; Willhite LA; Stumbo PJ; Berg MJ
    Ann Pharmacother; 1995; 29(7-8):726-35. PubMed ID: 8520091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenytoin treatment and folate supplementation affect folate concentrations and methylation capacity in rats.
    Carl GF; Smith ML; Furman GM; Eto I; Schatz RA; Krumdieck CL
    J Nutr; 1991 Aug; 121(8):1214-21. PubMed ID: 1861170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Michaelis-Menten kinetics and the steady-state serum phenytoin/hydroxyphenytoin ratio.
    Bourgeois BF; Wad N
    Ther Drug Monit; 1985; 7(4):405-10. PubMed ID: 4082240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible mechanisms for the pharmacokinetic interaction between phenytoin and folinate in rats.
    Yamasaki D; Tsujimoto M; Ohdo S; Ohtani H; Sawada Y
    Ther Drug Monit; 2007 Aug; 29(4):404-11. PubMed ID: 17667793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenytoin and folic acid interaction: a preliminary report.
    Berg MJ; Fischer LJ; Rivey MP; Vern BA; Lantz RK; Schottelius DD
    Ther Drug Monit; 1983; 5(4):389-94. PubMed ID: 6659012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind randomized study comparing brand-name and generic phenytoin monotherapy.
    Mikati M; Bassett N; Schachter S
    Epilepsia; 1992; 33(2):359-65. PubMed ID: 1547767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose adjustment of phenytoin for comedication in Japanese patients with epilepsy.
    Fukuoka N; Uno J; Tsukamoto T; Houchi H; Kimura M; Morita S
    Ther Drug Monit; 2009 Feb; 31(1):57-62. PubMed ID: 19077928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absolute bioavailability of phenytoin after 3-phosphoryloxymethyl phenytoin disodium (ACC-9653) administration to humans.
    Jamerson BD; Donn KH; Dukes GE; Messenheimer JA; Brouwer KL; Powell JR
    Epilepsia; 1990; 31(5):592-7. PubMed ID: 2401249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate.
    Sachdeo R; Wagner ML; Sachdeo S; Shumaker RC; Lyness WH; Rosenberg A; Ward D; Perhach JL
    Epilepsia; 1999 Aug; 40(8):1122-8. PubMed ID: 10448826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbamazepine-phenytoin interaction: elevation of plasma phenytoin concentrations due to carbamazepine comedication.
    Zielinski JJ; Haidukewych D; Leheta BJ
    Ther Drug Monit; 1985; 7(1):51-3. PubMed ID: 3992622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: studies in stereoselective hydroxylation and population pharmacokinetics.
    Mamiya K; Ieiri I; Shimamoto J; Yukawa E; Imai J; Ninomiya H; Yamada H; Otsubo K; Higuchi S; Tashiro N
    Epilepsia; 1998 Dec; 39(12):1317-23. PubMed ID: 9860067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenytoin half-life and clearance during maintenance therapy in adults and elderly patients with epilepsy.
    Ahn JE; Cloyd JC; Brundage RC; Marino SE; Conway JM; Ramsay RE; White JR; Musib LC; Rarick JO; Birnbaum AK; Leppik IE
    Neurology; 2008 Jul; 71(1):38-43. PubMed ID: 18591503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative bioavailability of orally administered fosphenytoin sodium injection compared with phenytoin sodium injection in healthy volunteers.
    Kaucher KA; Acquisto NM; Rao GG; Kaufman DC; Huntress JD; Forrest A; Haas CE
    Pharmacotherapy; 2015 May; 35(5):482-8. PubMed ID: 26011141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vigabatrin-induced decrease in serum phenytoin concentration does not involve a change in phenytoin bioavailability.
    Gatti G; Bartoli A; Marchiselli R; Michelucci R; Tassinari CA; Pisani F; Zaccara G; Timmings P; Richens A; Perucca E
    Br J Clin Pharmacol; 1993 Dec; 36(6):603-6. PubMed ID: 12959280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patients.
    Sachdeo RC; Sachdeo SK; Levy RH; Streeter AJ; Bishop FE; Kunze KL; Mather GG; Roskos LK; Shen DD; Thummel KE; Trager WF; Curtin CR; Doose DR; Gisclon LG; Bialer M
    Epilepsia; 2002 Jul; 43(7):691-6. PubMed ID: 12102670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derivation and evaluation of an equation for prediction of free phenytoin concentration in patients co-medicated with valproic acid.
    Haidukewych D; Rodin EA; Zielinski JJ
    Ther Drug Monit; 1989; 11(2):134-9. PubMed ID: 2497562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.